Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3

European Journal of Biochemistry

Volumn 267, Issue 9, 2000, Pages 2505-2515

  Achen, Marc G ^a   Roufail, Sally ^a   Domagala, Teresa ^a   Catimel, Bruno ^a   Nice, Edouard C ^a   Geleick, Detlef M ^a   Murphy, Roger ^a   Scott, Andrew M ^a   Caesar, Carol ^a   Makinen, Taija ^b   Alitalo, Kari ^b   Stacker, Steven A ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Angiogenesis; Inhibitor; Lymphangiogenesis; Monoclonal antibody; VEGF D

Indexed keywords

COMPLEMENTARY RNA; MONOCLONAL ANTIBODY; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LYMPH VESSEL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BASE SEQUENCE; CELL DIVISION; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EPITOPE MAPPING; HUMANS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

MAMMALIA;

EID: 0034125414     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01257.x     Document Type: Article

References (52)

1. 1. Achen, M.G. & Stacker, S.A. (1998) The vascular endothelial growth factor family; proteins which guide the development of the vasculature. Int. J. Exp. Path. 79, 255-265.
2. 2. Carmeliet, P., Ferreira, V., Breier, G., Pollofeyt, S., Keickens, L., Gertenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declerq, C., Pawling, J., Moons, L., Collen, D., Risau, W. & Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
3. 3. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powel-Braxton, L., Hillan, K.J. & Moore, M.W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-443.
4. 4. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. & Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844.
5. 5. Saleh, M., Stacker, S.A. & Wilks, A.F. (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res. 56, 393-401.
6. 6. De Vries, C., Escobedo, J.A., Ueno, H., Houck, K., Ferrara, N. & Williams, L.T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991.
7. 7. Peters, K.G., De Vries, C. & Williams, L.T. (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl Acad. Sci. USA 90, 8915-8919.
8. 8. Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Moller, N.P.H., Risau, W. & Ullrich, A. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
9. 9. Quinn, T.P., Peters, K.G., De Vries, C., Ferrara, N. & Williams, L.T. (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl Acad. Sci. USA 90, 7533-7537.
10. 10. Plate, K.H., Breier, G., Millauer, B., Ullrich, A. & Risau, W. (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53, 5822-5827.
11. 11. Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu, X.F., Breitman, M.L. & Schuh, A.C. (1995) Failure of blood-island formation and vasculogenesis in flk-1-deficient mice. Nature 376, 62-66.
12. 12. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W. & Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant. Nature 367, 576-579.
13. 13. Millauer, B., Longhi, M.P., Plate, K.H., Shawver, L.K., Risau, W., Ullrich, A. & Strawn, L.M. (1996) Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56, 1615-1620.
14. 14. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N. & Alitalo, K. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 290-298.
15. 15. Witzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., Principe, N., Kearney, M., Hu, J.-S. & Isner, J.M. (1998) Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol. 153, 381-394.
16. 16. Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J.H., Claesson-Welsh, L. & Alitalo, K. (1998) Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl Acad. Sci. USA 95, 14389-14394.
17. 17. Oh, S.-J., Jeltsch, M.M., Birkenhäger, R., McCarthy, J.E.G., Weich, H.A., Christ, B., Alitalo, K. & Wilting, J. (1997) VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188, 96-109.
18. 18. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R.K. & Alitalo, K. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425.
19. 19. Taipale, J., Makinen, T., Arighi, E., Kukk, E., Karkkainen, M. & Alitalo, K. (1999) Vascular endothelial growth factor receptor-3. Curr. Top. Microbiol. Immunol. 237, 85-96.
20. 20. Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V.W., Fang, G.H., Dumont, D., Breitman, M. & Alitalo, K. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl Acad. Sci. USA 92, 3566-3570.
21. 21. Orlandini, M., Marconcini, L., Ferruzzi, R. & Oliviero, S. (1996) Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc. Natl Acad. Sci. USA 93, 11675-11680.
22. 22. Achen, M.G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A.F., Alitalo, K. & Stacker, S.A. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4). Proc. Natl Acad. Sci. USA 95, 548-553.
23. 23. Marconcini, L., Marchio, S., Morbidelli, L., Cartocci, E., Albini, A., Ziche, M., Bussolino, F. & Oliviero, S. (1999) c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc. Natl Acad. Sci. USA 96, 9671-9676.
24. 24. Stacker, S.A., Stenvers, K., Ceasar, C., Vitali, A., Domagala, T., Nice, E., Roufail, S., Simpson, R.J., Moritz, R., Karpanen, T., Alitalo, K. & Achen, M.G. (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J. Biol. Chem. 274, 32127-32136.
25. 25. Avantaggiato, V., Orlandini, M., Acampora, D., Oliviero, S. & Simeone, A. (1998) Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor/vascular endothelial growth factor family. Mech. Dev. 73, 221-224.
26. 26. Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N. & Alitalo, K. (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16, 3898-3911.
27. 27. Stacker, S.A., Vitali, A., Caesar, C., Domagala, T., Groenen, L.C., Nice, E., Achen, M.G. & Wilks, A.F. (1999) A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability. J. Biol. Chem. 274, 34884-34892.
28. 28. Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R. & Alitalo, K. (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52, 5738-5743.
29. 29. D'Andrea, A.D., Lodish, H.F. & Wong, G.G. (1989) Expression cloning of the murine erythropoietin receptor. Cell 57, 277-285.
30. 30. Mizushima, S. & Nagata, S. (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18, 5322.
31. 31. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T. & Mulligan, R.C. (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
32. 32. Lymboussaki, A., Partanen, T.A., Olofsson, B., Thomas-Crusells, J., Fletcher, C.D.M., de Waal, R.M.W., Kaipainen, A. & Alitalo, K. (1998) Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am. J. Pathol. 153, 395-403.
33. 33. Bernardi, P., Patel, V.P. & Lodish, H.F. (1987) Lymphoid precursor cells adhere to two different sites on fibronectin. J. Cell. Biol. 105, 489-498.
34. 34. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
35. 35. Nice, E.C. & Catimel, B. (1999) Instrumental biosensors: new perspectives for the analysis of biomolecular interactions. Bioessays 21, 339-352.
36. 36. Catimel, B., Domagala, T., Nerrie, M., Weinstock, J., White, S., Abud, H., Heath, J. & Nice, E. (1999) Recent applications of instrumental biosensors for protein and peptide structure-function studies. Protein Peptide Lett. 6, 319-340.
37. 37. Catimel, B., Nerrie, M., Lee, F.T., Scott, A.M., Ritter, G., Welt, S., Old, L.J., Burgess, A.W. & Nice, E.C. (1997) Kinetic analysis of the interaction between the monoclonal antibody A33 and its colonic epithelial antigen by the use of an optical biosensor. A comparison of immobilisation strategies. J. Chromatogr. A 776, 15-30.
38. 38. Nice, E., Layton, J., Fabri, L., Hellman, U., Engstrom, A., Persson, B. & Burgess, A.W. (1993) Mapping of the antibody-and receptor-binding domains of granulocyte colony-stimulating factor using an optical biosensor. Comparision with enzyme-linked immunosorbent assay competition studies. J. Chromatogr. 646, 159-168.
39. 39. Stenberg, E., Persson, B., Roos, H. & Urbaniczki, J. (1990) Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J. Colloid Interface 43, 513-526.
40. 40. Pacifici, R.E. & Thomason, A.R. (1994) Hybrid tyrosine kinase/ cytokine receptors transmit mitogenic signals in response to ligand. J. Biol. Chem. 269, 1571-1574.
41. 41. Keyt, B.A., Nguyen, H.V., Berleau, L.T., Duarte, C.M., Park, J., Chen, H. & Ferrara, N. (1996) Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. J. Biol. Chem. 271, 5638-5646.
42. 42. Wiesmann, C., Fuh, G., Christinger, H.W., Eigenbrot, C., Wells, J.A. & de Vos, A.M. (1997) Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91, 695-704.
43. 43. Wise, L.M., Veikkola, T., Mercer, A.A., Savory, L.J., Fleming, S.B., Caesar, C., Vitali, A., Makinen, T., Alitalo, K. & Stacker, S.A. (1999) Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc. Natl Acad. Sci. USA 96, 3071-3076.
44. 44. Breier, G., Albrecht, U., Sterrer, S. & Risau, W. (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521-532.
45. 45. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V. & Alitalo, K. (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122, 3829-3837.
46. 46. Salven, P., Heikkilä, P. & Joensuu, H. (1997) Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br. J. Cancer 76, 930-934.
47. 47. Valtola, R., Salven, P., Heikkila, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R. & Alitalo, K. (1999) VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 154, 1381-1390.
48. 48. Kumar-Singh, S., Weyler, J., Martin, M.J., Vermeulen, P.B. & Van Marck, E. (1999) Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF-β expression. J. Pathol. 189, 72-78.
49. 49. Bayer-Garner, I.B., Hough, A.J.J. & Smoller, B.R. (1999) Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness. Mod. Pathol. 12, 770-774.
50. 50. Breiteneder-Geleff, S., Soleiman, A., Kowalski, H., Horvat, R., Amann, G., Kriehuber, E., Diem, K., Weninger, W., Tschachler, E., Alitalo, K. & Kerjaschki, D. (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154, 385-394.
51. 51. Weninger, W., Partanen, T.A., Breiteneder-Geleff, S., Mayer, C., Kowalski, H., Mildner, M., Pammer, J., Sturzl, M., Kerjaschki, D., Alitalo, K. & Tschachler, E. (1999) Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab. Invest. 79, 243-251.
52. 52. Kawamoto, T., Sato, J.D., Le, A., Polikoff, J., Sato, G.H. & Mendelsohn, J. (1983) Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc. Natl Acad. Sci. USA 80, 1337-1341.